The FY26 Defense Appropriations Act provides funding for the NFRP to support innovative, high-impact research with clinical relevance that will improve the understanding, diagnosis and treatment Neurofibromatosis and schwannomatosis to enhance the quality of life for persons with these disorders.

The NFRP provides the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunities.

The FY26 Defense Appropriations Act provides funding for the PCRP to support innovative, high-impact research with clinical relevance that will eliminate death and suffering from prostate cancer. As part of the DHA R&D-MRDC, the CDMRP is the program office managing these anticipated FY26 funding opportunities.

The PCRP provides the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunities.

Cures Within Reach has an open Request for Proposals (RFP) for Clinical Repurposing Research to Impact US Veterans/Military. This RFP supports clinical trials that repurpose approved drugs, devices, nutraceuticals and/or diagnostics, as well as combination therapies to address unmet and high-priority medical needs of US veterans/military, including mental health, PTSD and brain injuries.

To submit a Letter of Intent (LOI) and for more details, visit https://bit.ly/cwrrfps.

LOI deadline is May 29.

WIVR is pleased to invite research proposals for the 2026 WIVR Research Grant Program, which provides up to $30,000 in start up funding to support pilot studies by new VA investigators.

Proposal deadline is May 30, 2026 (by midnight)